Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
A randomized controlled study is conducted on patients with resected gastric cancer assigned
to postoperative adjuvant therapy of TS-1 alone or PSK combined with TS-1, with the objective
to examine or validate the outcome, QOL and prognostic factors (host and tumor factors), and
explore the factors enhancing the antitumor effect of TS-1.